EUVIMEDEUVIMED entdecken
Vergleichsstudie

The Comparation of Renal Anti‐Senescence Effects and Blood Metabolites between Dapagliflozin and Metformin in Non‐Diabetes Environment

Lu Zeng iD, Lei Chen, Fanfan Gao, Jie Li, Yangyang Song, Limin Wei, Ning Qu, Yan Li, Hongli Jiang iD

Advanced Biology · 2023

DOI: 10.1002/adbi.202300199 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Advanced Biology, 2023. Verfasst von Lu Zeng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Nephrology and Blood Purification, the First Affiliated Hospital of Xi'an Jiaotong University, Shannxi, 710061, China. Hauptthemen laut MEDLINE: Metformin, Benzhydryl Compounds, Glucosides, Kidney. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Delaying kidney senescence process will benefit renal physiologic conditions, and prompt the kidney recovering from different pathological states. The renal anti‐senescence effects of sodium‐glucose cotransporter‐2 inhibitors (SGLT2i) and metformin have been proven in diabetic settings, but the roles of each one and combination of two drugs in natural kidney aging process remain undefined and deserve further research. Senescence‐accelerated mouse prone 8 (SAMP8) were orally administered dapagliflozin, metformin, and a combination of them for 16 weeks. Dapagliflozin exhibits better effects than metformin in lowering senescence related markers, and the combination therapy shows the best results. In vitro experiments demonstrate the same results that the combination of dapagliflozin and metformin can exert a better anti‐senescence effect. Blood metabolites detection in vivo shows dapagliflozin mainly leads to the change of blood metabolites enriched in choline metabolism, and metformin tends to induce change of blood metabolites enriched in purine metabolism. In conclusion, the results suggest dapagliflozin may have a better renal anti‐senescence effect than metformin in non‐diabetes environment, and the combination of the two drugs can strengthen the effect. The two drugs can lead to different blood metabolites alteration, which may lead to different systemic effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetforminBenzhydryl CompoundsGlucosidesKidneyCellular SenescenceAnimalsMiceSodium-Glucose Transporter 2 InhibitorsMaleHypoglycemic Agents

Stichwörter der Autor:innen

SGLT2dapagliflozinkidneymetabolitesmetforminsenescence

Substanzen

MetforminBenzhydryl CompoundsdapagliflozinGlucosidesSodium-Glucose Transporter 2 InhibitorsHypoglycemic Agents

Autor:innen und Institutionen

  • Department of Critical Care Nephrology and Blood Purification, the First Affiliated Hospital of Xi'an Jiaotong University, Shannxi, 710061, China.
  • Department of Obstetrics and Gynecology, the First Affiliated Hospital of Xi'an Jiaotong University, Shannxi, 710061, China.
  • Department of Nephrology, Henan Provincial people's hospital, Henan, 450003, China.
  • Department of Medical Examination, the First Affiliated Hospital of Xi'an Jiaotong University, Shannxi, 710061, China.
  • Department of Nephrology, the First Affiliated Hospital of Xi'an Jiaotong University, Shannxi, 710061, China.

ORCID-Profile: Lu Zeng, Hongli Jiang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zeng, L., Chen, L., Gao, F., Li, J., Song, Y., Wei, L., Qu, N., Li, Y., & Jiang, H. (2023). The Comparation of Renal Anti‐Senescence Effects and Blood Metabolites between Dapagliflozin and Metformin in Non‐Diabetes Environment. Advanced Biology. https://doi.org/10.1002/adbi.202300199

Vancouver

Zeng L, Chen L, Gao F, Li J, Song Y, Wei L, et al. The Comparation of Renal Anti‐Senescence Effects and Blood Metabolites between Dapagliflozin and Metformin in Non‐Diabetes Environment. Advanced Biology. 2023. doi:10.1002/adbi.202300199

BibTeX
@article{Zeng2023,
  author = {Zeng, Lu and Chen, Lei and Gao, Fanfan and Li, Jie and Song, Yangyang and Wei, Limin and Qu, Ning and Li, Yan and Jiang, Hongli},
  title = {The Comparation of Renal Anti‐Senescence Effects and Blood Metabolites between Dapagliflozin and Metformin in Non‐Diabetes Environment},
  journal = {Advanced Biology},
  year = {2023},
  doi = {10.1002/adbi.202300199}
}
Kostenlos starten →